Skip to content
Catalyst
Parkinson's disease incidence

3 findings · 3 compounds · 1 null · by evidence strength. No dose is advised.

Fig. 2 Parkinson's disease incidence3 compounds outer ring on requestSelected Parkinson's disease incidence · centre
×1.60
Labels
Measured outcomeInspector

Parkinson's disease incidence

Findings drawn, by strength

3findings · 3 compounds

  • Very limited3
Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

Compound lowers no difference foundFindingsStrongest
1
Very limited
1
Very limited
1
Very limited

Not pooled · no summary effect · point at a mark · Tab, then the arrow keys

Reported to move it2 findings

  1. CaffeineMoved: lowersEvidence: Very limitedPaper: PMID 225057632012
    Who
    Men and women in the NIH-AARP Diet and Health Study
    Dose studied
    not reported

    Higher caffeine intake as assessed in 1995-1996 was monotonically associated with lower PD risk (diagnosed in 2000-2006) in both men and women.”

    Quoted verbatim from Caffeine intake, smoking, and risk of Parkinson disease in men and women.cohortPermalink
  2. PyridoxineMoved: lowersEffect, as reportedHR0.69[0.5 to 0.96]Evidence: Very limitedPaper: PMID 168648262006
    Who
    Community-dwelling adults aged 55 years and older, free of dementia and parkinsonism at baseline (Rotterdam Study); dietary intake by food frequency assessment
    Dose studied
    dietary vitamin B6 intake, per SD

    Higher dietary intake of vitamin B6 was associated with a significantly decreased risk of PD (hazard ratio per SD, 0.69 [95% CI 0.50 to 0.96]; for highest vs lowest tertile, 0.46 [0.22 to 0.96]).”

    Quoted verbatim from Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease.cohortPermalink

Measured, no difference found1 finding

  1. ZincMoved: no difference foundEvidence: Very limitedPaper: PMID 262652932015
    Who
    Participants in five observational studies (126,507 individuals) of dietary intake; moderate or high versus lowest intake
    Dose studied
    moderate or high dietary zinc intake versus lowest

    The pooled RRs of Parkinson's disease for moderate or high intake of zinc, and copper were not statistically different (P > 0.05).”

    Quoted verbatim from Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.meta-analysisPermalink

How it is measured

Incident Parkinson's disease diagnosis in a population, ascertained by clinical diagnosis or registry-based ascertainment criteria.

Papers about it

As an endpoint5

Show the papersHide the papers
  • Vitamin C, vitamin E, β-carotene and risk of Parkinson's disease: a systematic review and dose-response meta-analysis of observational studies.

    Nutritional neuroscience2024PMID 36961747Via: named in the paper, as read

  • Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.

    Neurological sciences2015PMID 26265293Via: named in the paper, as read

  • Caffeine intake, smoking, and risk of Parkinson disease in men and women.

    American journal of epidemiology2012PMID 22505763Via: named in the paper, as read

  • Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease.

    Neurology2006PMID 16864826Via: named in the paper, as read

  • Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis.

    The Lancet. Neurology2005PMID 15907740Via: named in the paper, as read

Newest

  • Vitamin C, vitamin E, β-carotene and risk of Parkinson's disease: a systematic review and dose-response meta-analysis of observational studies.

    Nutritional neuroscience2024PMID 36961747As an endpoint

  • Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis.

    Neurological sciences2015PMID 26265293As an endpoint

  • Caffeine intake, smoking, and risk of Parkinson disease in men and women.

    American journal of epidemiology2012PMID 22505763As an endpoint

  • Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease.

    Neurology2006PMID 16864826As an endpoint

  • Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis.

    The Lancet. Neurology2005PMID 15907740As an endpoint